Skip to content

Quantitative Analysis of Retinal Neural Structure, Vascular Changes and Blood Glucose Control in Patients with Type 1 Diabetic Retinopathy

Quantitative Analysis of Retinal Neural Structure, Vascular Changes and Blood Glucose Control in Patients with Type 1 Diabetic Retinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098331
Enrollment
Unknown
Registered
2025-03-06
Start date
2025-03-25
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

Type 1 diabetes mellitus with diabetic retinopathy:None
Type 1 diabetic group without diabetic retinopathy:None

Sponsors

First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with T1DM who meet the standards published by the ADA; 2) Meet the evaluation of eye exams by professional ophthalmologists and the 'International Clinical Grading Standards for Diabetic Retinopathy (DR)' published by the American Academy of Ophthalmology in 2019.

Exclusion criteria

Exclusion criteria: 1) Type 2 diabetes, gestational diabetes and other specific types of diabetes; 2) Hospitalized patients mainly diagnosed with diabetic ketoacidosis, diabetic hyperosmolar coma and other acute complications of diabetes; 3) Active or chronic inflammation, active infection, autoimmune disease; 4) Blood diseases, recent blood transfusion before enrollment, malignant tumors; 5) Acute or chronic kidney/liver disease; 6) Other eye diseases affecting the diagnosis of DR, such as macular degeneration, retinal vein obstruction, and glaucoma, were excluded; 7) Incomplete basic information, such as medication history and past medical history.

Design outcomes

Primary

MeasureTime frame
Retinal Nerve Fiber Layer Thickness;Foveal and peripapillary vessel density;Time in Range;

Secondary

MeasureTime frame
Glycosylated Hemoglobin;Urine microalbumin;

Countries

China

Contacts

Public ContactHongyu Kuang

First Affiliated Hospital of Harbin Medical University

Ydykuanghongyu@126.com+86 1339300885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026